International Biotechnology Trust (LSE:IBT) Dividends Paid

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:IBT International Biotechnology Trust PLC LSE:IBT
42 GF Score
Price £11.10
GF Value £28.13
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust Dividends Paid?

Dividends Paid only applicable to companies reporting Cash Flow from Operations in direct method.

LSE:IBT
42GF Score
International Biotechnology Trust PLC LSE:IBT
Dividends Paid is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is International Biotechnology Trust (LSE:IBT) Overvalued in 2026?

Based on GuruFocus' analysis, International Biotechnology Trust stock appears to be undervalued. The current stock price of £11.10 is trading 60.5% below its estimated GF Value™ of £28.13. GuruFocus considers International Biotechnology Trust to be Significantly Undervalued.

Key valuation signals for LSE:IBT:

  • Dividends Paid:
  • GF Value™: £28.13 vs. price of £11.10 (60.5% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the LSE:IBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
42GF Score

Get the complete analysis for LSE:IBT

Dividends Paid is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£11.10
Price
£28.13
GF Value